| |
| |
CDMOs’ Critical Role in a Rapidly
Evolving Biopharma Landscape |
|
|
Date: Thursday, July 11th, 2024
Time: 11:00 AM EDT |
|
|
| |
It is an incredibly dynamic time for CDMOs. With increased awareness of the sector and its growing importance in the pharmaceutical supply chain, CDMOs have become broadly acknowledged as a critical part of the solution for meeting industry challenges, including accessing technologies and capacity, addressing regulatory complexity, and managing fixed costs and investments. Tune in to hear Catalent President and CEO Alessandro Maselli discuss these topics with Endpoints News founder John Carroll and the evolving role of CDMOs, and also touch on what’s next for Catalent, as it progresses with its shift from public to private ownership under its previously announced transaction with Novo Holdings. |
|
|
| |
Alessandro Maselli
President & Chief Executive Officer
Catalent
|
|
|
| |
| |
John Carroll
Editor & Founder
Endpoint News
|
|
|
| |
Every project has a challenge. We have a solution.
|
|
|
| |
or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
